The changing aetiology of paediatric bacteraemia in England and Wales, 1998-2007

Katherine L Henderson1, Alan P Johnson1, Berit Muller-Pebody1

  • 1Department of Healthcare-Associated Infection and Antimicrobial Resistance, Health Protection Agency Centre for Infections, London, UK.

Insights

Bacteraemia in children increased annually from 1998-2007. Coagulase-negative staphylococci and Staphylococcus aureus were the most common causes, while vaccine-preventable pathogens decreased significantly.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Microbiology
  • Epidemiology

Background:

  • Bacteraemia in children is a serious, potentially life-threatening condition requiring ongoing surveillance.
  • Understanding trends in pediatric bacteraemia is crucial for effective public health strategies and clinical management.
  • Previous studies have indicated shifts in causative pathogens, necessitating updated epidemiological data.

Purpose of the Study:

  • To determine the etiological trends of bacteraemia in children aged 1 month to 15 years in England and Wales.
  • To analyze changes in bacterial species causing bacteraemia over a 10-year period (1998-2007).
  • To assess the impact of vaccination programs on the incidence of specific vaccine-preventable pathogens.

Main Methods:

  • Voluntary data collection from National Health Service hospital microbiology laboratories across England and Wales.
  • Analysis of 51,788 reported bacteraemia cases over the 10-year study period (1998-2007).
  • Identification and quantification of bacterial genera and species responsible for pediatric bacteraemia.

Main Results:

  • Total annual bacteraemia reports increased from 4125 to 6916, a mean annual increase of 6.5%.
  • In 2007, coagulase-negative staphylococci (28%), Staphylococcus aureus (10%), non-pyogenic streptococci (9%), and Streptococcus pneumoniae (7%) were the most frequent causes.
  • Significant decreases in bacteraemia were observed for Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae following vaccine introductions.

Conclusions:

  • This study identified the predominant bacterial causes of pediatric bacteraemia in England and Wales.
  • Significant shifts in etiological trends were observed over the decade, including a decline in vaccine-preventable diseases.
  • Continued surveillance is essential to monitor evolving patterns of pediatric bacteraemia and inform public health interventions.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...